Pregled bibliografske jedinice broj: 1260998
Comprehensive geriatric assessment in older people: an umbrella review of health outcomes
Comprehensive geriatric assessment in older people: an umbrella review of health outcomes // Age and ageing, 51 (2022), 5; afac104, 12 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1260998 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comprehensive geriatric assessment in older people:
an umbrella review of health outcomes
Autori
Veronese, Nicola ; Custodero, Carlo ; Demurtas, Jacopo ; Smith, Lee ; Barbagallo, Mario ; Maggi, Stefania ; Cella, Alberto ; Vanacore, Nicola ; Lora Aprile, Pierangelo ; Ferrucci, Luigi ; Pilotto, Alberto
Kolaboracija
Special Interest Group in Systematic Reviews of the European Geriatric Medicine Society (EuGMS) ; Special Interest Group in Meta-analyses and Comprehensive Geriatric Assessment of the European Geriatric Medicine Society (EuGMS)
Izvornik
Age and ageing (0002-0729) 51
(2022), 5;
Afac104, 12
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
comprehensive geriatric assessment ; older people ; systematic review ; umbrella review.
Sažetak
Background: Comprehensive geriatric assessment (CGA) has been in use for the last three decades. However, some doubts remain regarding its clinical use. Therefore, we aimed to capture the breadth of outcomes reported and assess the strength of evidence of the use of comprehensive geriatric assessment (CGA) for health outcomes in older persons. Methods: Umbrella review of systematic reviews of the use of CGA in older adults searching in Pubmed, Embase, Scopus, Cochrane library and CINHAL until 05 November 2021. All possible health outcomes were eligible. Two independent reviewers extracted key data. The grading of evidence was carried out using the GRADE for intervention studies, whilst data regarding systematic reviews were reported as narrative findings. Results: Among 1, 683 papers, 31 systematic reviews (19 with meta-analysis) were considered, including 279, 744 subjects. Overall, 13/53 outcomes were statistically significant (P < 0.05). There was high certainty of evidence that CGA reduces nursing home admission (risk ratio [RR] = 0.86 ; 95% confidence interval [CI]: 0.75-0.89), risk of falls (RR = 0.51 ; 95%CI: 0.29-0.89), and pressure sores (RR = 0.46 ; 95%CI: 0.24-0.89) in hospital medical setting ; decreases the risk of delirium (OR = 0.71 ; 95%CI: 0.54-0.92) in hip fracture ; decreases the risk of physical frailty in community-dwelling older adults (RR = 0.77 ; 95%CI: 0.64-0.93). Systematic reviews without meta- analysis indicate that CGA improves clinical outcomes in oncology, haematology, and in emergency department. Conclusions: CGA seems to be beneficial in the hospital medical setting for multiple health outcomes, with a high certainty of evidence. The evidence of benefits is less strong for the use of CGA in other settings.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE